Press releases

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®,...

FRANKLIN LAKES, N.J., Mar. 30, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that BD MedMined(®) Surveillance Advisor has been named a 2015/2016 Category Leader for...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a definitive agreement to sell 50.1 percent of its Respiratory Solutions business to...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys(TM)...

FRANKLIN LAKES, N.J., March 1, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in Europe for a...

BD Vacutainer® Barricor(TM) Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time FRANKLIN LAKES, N.J., March 1, 2016 /PRNewswire/ -- BD...

LAS VEGAS, March 1, 2016 –BD (Becton, Dickinson and Company), a leading global medical technology company, is utilizing AT&T* Internet of Things (IoT) services to connect wireless health...

FRANKLIN LAKES, N.J., Feb. 24, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Alaris™ System has been named 2015...

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: 2016 RBC...